drugset / Trial / NCT03407716
Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
RandomizedCrossoverDouble-blindSupportive care
Summary
This randomized pilot trial studies how well North American ginseng extract AFX-2 (ginseng) works in decreasing cancer-related fatigue after treatment in cancer survivors. Ginseng may decrease fatigue in people who were treated for cancer.
Timeline
- Start
- 2019-03-01
- Primary completion
- 2020-05-13
- Completion
- 2021-02-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | American ginseng | Unknown | 2000 mg | Oral |